Acute myeloid leukemia (AML) is a malignant tumor of the immature myeloid hematopoietic
cells in the bone marrow (BM). It is a highly heterogeneous disease, with rising morbidity …

Simple Summary Dysregulated microRNA (miRNA) expression has been described in the
initiation and progression of a wide spectrum of hematologic malignancies. Moreover …

Immune cells play important roles in systemic lupus erythematosus (SLE). We previously
found that myeloid-derived suppressor cell (MDSC)-derived arginase-1 (Arg-1) promoted …

Myeloid-derived suppressor cells (MDSCs) are a group of immature myeloid cells that play
an important role in diseases. MDSCs promote Th17 differentiation and aggravate systemic …

Current tumor-node-metastasis (TNM) stage is unable to accurately predict the overall
survival (OS) in breast cancer (BC) patients. This study aimed to construct a microRNA …

BACKGROUND: Increasing evidence have demonstrated that serum extracellular vesicle
microRNAs (EV-miRNAs) are promising noninvasive biomarkers for various cancer types …

Novel therapeutic strategies are needed for paediatric patients affected by Acute Myeloid
Leukaemia (AML), particularly for those at high-risk for relapse. MicroRNAs (miRs) have …

MicroRNAs (miRNAs) are evolutionarily conserved small non-coding RNAs, that are
involved in the multistep process of carcinogenesis, contributing to all established hallmarks …

Accurately predicting patient outcomes is essential for optimizing treatment and improving
outcomes in pediatric acute myeloid leukemia (AML). In recent years, microRNAs have …

Early-stage leukemia identification is crucial for effective disease management and leads to
an improvement in the survival of leukemia patients. Approaches based on cutting-edge …